Kim M K, Niyibizi C
Department of Orthopaedic Surgery, Inha University Hospital, Incheon, Korea.
Yonsei Med J. 2001 Jun;42(3):338-44. doi: 10.3349/ymj.2001.42.3.338.
Transforming growth factor-beta1 (TGF-beta1) and bone morphogenetic protein-2 (BMP-2) are abundant proteins in the bone matrix. However, their interaction in controlling osteoblast differentiation is not clearly understood. In this study, HBMSCs were cultured in collagen gel matrix with different condition of exogenous rhBMP-2 and TGF-beta1 in order to determine the interaction of BMP-2 and TGF-beta1 on human bone marrow stromal cells (HBMSCs) differentiation. The cultured cells were analyzed for cell proliferation, alkaline phophatase (ALP) activity and mineralization staining with Von-Kossa. The cells treated with TGF-beta1 exhibited a higher rate of cell growth than those without. However, the cells cultured in collagen gel matrix showed a lower rate of cell growth than the cells cultured in a monolayer. To investigate the effects of both cytokines on osteoblast differentiation, the cells were treated with 0, 1, 5, 10 ng/ml of TGF-beta1 for 2 days. This was followed by culturing with 0, 1, 5, and 10 ng/ml of TGF-beta1 and 100 ng/ml of rhBMP-2 together for 3 days with the alkaline phosphatase (ALP) activity measured. The cells treated with 1 ng/ml of TGF-beta1 responded efficiently to rhBMP-2 and expressed ALP activity with a level equivalent to that exhibited by cells that were not treated with TGF-beta1. The cells treated with 5 and 10 ng/ml of TGF-beta1 showed a dramatic decrease in ALP activity. The cells treated with 10 ng/ml of TGF-beta1 followed by rhBMP-2 alone exhibited an intermediate ALP activity. The cells treated with 100 ng/ml of rhBMP-2 demonstrated Von-Kossa positive solid deposits after 3 weeks, while there were few Von-Kossa positive solid deposits when the cells treated with 10 ng/ml of TGF-beta1. These results show that TGF-beta1 inhibits the effects of rhBMP-2 on the osteoblast differentiation of HBMSCs in a dose dependant manner. Furthermore, the effects of TGF-beta1 on HBMSCs are reversible. This suggest that TGF-beta1 and rhBMP-2 are coordinately controlled during the osteoblast differentiation of HMBSCs.
转化生长因子-β1(TGF-β1)和骨形态发生蛋白-2(BMP-2)是骨基质中含量丰富的蛋白质。然而,它们在控制成骨细胞分化过程中的相互作用尚不清楚。在本研究中,将人骨髓间充质干细胞(HBMSCs)培养于含有不同条件外源性重组人骨形态发生蛋白-2(rhBMP-2)和TGF-β1的胶原凝胶基质中,以确定BMP-2和TGF-β1对人骨髓间充质干细胞(HBMSCs)分化的相互作用。对培养的细胞进行细胞增殖、碱性磷酸酶(ALP)活性分析以及用Von-Kossa法进行矿化染色。用TGF-β1处理的细胞比未处理的细胞表现出更高的细胞生长速率。然而,在胶原凝胶基质中培养的细胞比单层培养的细胞表现出更低的细胞生长速率。为了研究这两种细胞因子对成骨细胞分化的影响,用0、1、5、10 ng/ml的TGF-β1处理细胞2天。随后,将细胞与0、1、5和10 ng/ml的TGF-β1以及100 ng/ml的rhBMP-2一起培养3天,并测定碱性磷酸酶(ALP)活性。用1 ng/ml的TGF-β1处理的细胞对rhBMP-2反应有效,并表达出与未用TGF-β1处理的细胞相当水平的ALP活性。用5和10 ng/ml的TGF-β1处理的细胞显示出ALP活性显著降低。先用10 ng/ml的TGF-β1处理然后单独用rhBMP-2处理的细胞表现出中等水平的ALP活性。用100 ng/ml的rhBMP-2处理的细胞在3周后显示出Von-Kossa阳性固体沉积物,而用10 ng/ml的TGF-β1处理的细胞几乎没有Von-Kossa阳性固体沉积物。这些结果表明,TGF-β1以剂量依赖性方式抑制rhBMP-2对HBMSCs成骨细胞分化的作用。此外,TGF-β1对HBMSCs的作用是可逆的。这表明在HMBSCs成骨细胞分化过程中,TGF-β1和rhBMP-2受到协同调控。